Stockreport

NexImmune to Announce Third Quarter 2021 Financial Results and Provide Corporate Update on November 12, 2021

NexImmune, Inc.  (NEXI) 
PDF GAITHERSBURG, Md., Nov. 08, 2021 (GLOBE NEWSWIRE) -- NexImmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology company developing a novel approach to immunotherap [Read more]